How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
And now that the protein-targeting technique exhibits promise, a number of firms have jumped into the fray. Dozens of similar drugs at the moment are being examined for cancers of the pancreas, lung and colon. The drug that opened the floodgates, daraxonrasib, has been fast-tracked for evaluation by the Food and Drug Administration and will…
